USE OF COMPOUNDS HAVING COMBINED DOPAMINE D2, 5-HT1A AND ALPHA ADRENORECEPTOR AGONISTIC ACTION FOR TREATING CNS DISORDERS
摘要
The invention relates to the use of compounds having combined sopamine D2 agonistic activity, 5-HT1A agonistic activity and a adrenoceptor agonistic activity for the treatment of CNS disorders such as Parkinson's disease.
申请公布号
WO0185168(A1)
申请公布日期
2001.11.15
申请号
WO2001EP05319
申请日期
2001.05.10
申请人
SOLVAY PHARMACEUTICALS B.V.;VAN DER HEIJDEN, JOHANNES, A., M.;LONG, STEPHEN, K.;FEENSTRA, ROELOF, W.;VAN SCHARRENBURG, GUSTAAF, J., M.
发明人
VAN DER HEIJDEN, JOHANNES, A., M.;LONG, STEPHEN, K.;FEENSTRA, ROELOF, W.;VAN SCHARRENBURG, GUSTAAF, J., M.
